Health Ministry asks states, UTs to review preparedness against respiratory illnesses in children

In view of the recent reports indicating a surge in respiratory illness in children in northern China in the recent weeks, Union Health Ministry on Sunday decided to to proactively review preparedness measures against respiratory illnesses.

In a letter by Union Health Secretary to states and UTs, they have been advised to immediately review public health and hospital preparedness measures viz. availability of HR, hospital beds, drugs and vaccines for influenza, medical oxygen, antibiotics, personal protective equipment, testing kits and reagents, functionality of oxygen plants and ventilators, infection control practices in health facilities, at a senior level.

"All states and union territories have ben advised to implement ‘Operational Guidelines for Revised Surveillance Strategy in the context of COVID-19’, shared earlier this year, which provides for integrated surveillance of respiratory pathogens presenting as cases of influenza like illness (ILI) and severe acute respiratory illness (SARI)," the health ministry said in a statement.

They have also been asked to ensure that the trends of ILI/SARI should be closely monitored by the district and state surveillance units of Integrated Disease Surveillance Project (IDSP), particularly of children and adolescents. 

The data of ILI/SARI is required to be uploaded on IDSP/IHIP portal particularly from the public health institutions including medical college hospitals.

States have also been asked to send nasal and throat swab samples of patients with SARI, particularly of children and adolescents, to Virus Research and Diagnostic 

Laboratories (VRDL’s) located in the States for testing for respiratory pathogens.

The cumulative effect of the implementation of these precautionary and proactive collaborative measures is expected to counter any potential situation and ensure the safety and well-being of the citizens.

Recently, information shared by WHO has indicated an increase in respiratory illness in northern parts of China.

This is predominantly attributed to usual causes like Influenza, Mycoplasma pneumonia, SARS-CoV-2 etc.

As per WHO, the release of COVID-19 restrictions coinciding with the onset of the winter season in addition to cyclical trend of respiratory illnesses such as Mycoplasma pneumonia have led to this surge.

While WHO has sought additional information from Chinese authorities, it is assessed that there is no cause for any alarm at the moment.